Estimated Economic Benefits During The 'Decade Of Vaccines' Include Treatment Savings, Gains In Labor Productivity
Estimated Economic Benefits During The 'Decade Of Vaccines' Include Treatment Savings, Gains In Labor Productivity
复制标题
DOI：
10.1377/hlthaff.2011.0382
复制
发表时间：
2011-06-01
期刊：
影响因子：
9.7
通讯作者：
Levine, Orin S.
中科院分区：
文献类型：
--
作者：
Stack, Meghan L.;Ozawa, Sachiko;Levine, Orin S.
2010年，比尔和梅琳达·盖茨基金会宣布在未来十年内投入100亿美元，以增加世界上最贫穷国家儿童疫苗的获得。这项工作被称为“疫苗十年”。“这项研究估计了2011年至2020年在世界上72个最贫穷国家引进和增加使用六种疫苗的短期和长期经济效益。在未来十年内，提高肺炎球菌和流感嗜血杆菌B型肺炎、脑膜炎、轮状病毒、百日咳、麻疹和疟疾的疫苗接种率将挽救640万人的生命，避免4.26亿例疾病，减少62亿美元的治疗费用和1450亿美元的生产力损失。基于这类分析的货币估计数可用于确定国际社会和地方政府对免疫接种的投资回报，并应在决策中予以考虑。
In 2010 the Bill & Melinda Gates Foundation announced a $10 billion commitment over the next ten years to increase access to childhood vaccines in the world's poorest countries. The effort was labeled the "Decade of Vaccines." This study estimates both the short-and long-term economic benefits from the introduction and increased use of six vaccines in seventy-two of the world's poorest countries from 2011 to 2020. Increased rates of vaccination against pneumococcal and Haemophilus influenzae type b pneumonia and meningitis, rotavirus, pertussis, measles, and malaria over the next ten years would save 6.4 million lives and avert 426 million cases of illness, $6.2 billion in treatment costs, and $145 billion in productivity losses. Monetary estimates based on this type of analysis can be used to determine the return on investment in immunization from both the international community and local governments, and they should be considered in policy making.